| parent | Tobramycin | LP16294-8 |
| child | Tobramycin [Mass/volume] in Serum or Plasma | 35670-9 |
| child | Tobramycin [Moles/volume] in Serum or Plasma | 50927-3 |
| child | Tobramycin [Mass/volume] in Serum or Plasma --peak | 4057-6 |
| child | Tobramycin [Moles/volume] in Serum or Plasma --peak | 22751-2 |
| child | Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing | 31094-6 |
| child | Tobramycin [Mass/volume] in Serum or Plasma --post dialysis | 59380-6 |
| child | Tobramycin [Mass/volume] in Serum or Plasma --random | 4058-4 |
| child | Tobramycin [Moles/volume] in Serum or Plasma --random | 22750-4 |
| child | Tobramycin [Mass/volume] in Serum or Plasma --random post extended interval dosing | 31096-1 |
| child | Tobramycin [Mass/volume] in Serum or Plasma --trough | 4059-2 |
| child | Tobramycin [Mass or Moles/volume] in Serum or Plasma --trough | 35239-3 |
| child | Tobramycin [Moles/volume] in Serum or Plasma --trough | 22752-0 |
| child | Tobramycin [Mass/volume] in Serum or Plasma --trough post extended interval dosing | 31095-3 |
| PartDisplayName | en-US | Tobramycin | Serum or Plasma | Drug toxicology |
LOINC Version: 2.77
FHIR